144 related articles for article (PubMed ID: 36522330)
1. Structural insights into p300 regulation and acetylation-dependent genome organisation.
Ibrahim Z; Wang T; Destaing O; Salvi N; Hoghoughi N; Chabert C; Rusu A; Gao J; Feletto L; Reynoird N; Schalch T; Zhao Y; Blackledge M; Khochbin S; Panne D
Nat Commun; 2022 Dec; 13(1):7759. PubMed ID: 36522330
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma.
Yu D; Liang Y; Kim C; Jaganathan A; Ji D; Han X; Yang X; Jia Y; Gu R; Wang C; Zhang Q; Cheung KL; Zhou MM; Zeng L
Nat Commun; 2023 Jan; 14(1):378. PubMed ID: 36690674
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.
Wang R; You J
J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383
[TBL] [Abstract][Full Text] [Related]
4. TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition.
Xu L; Xuan H; He W; Zhang L; Huang M; Li K; Wen H; Xu H; Shi X
Nat Commun; 2023 Sep; 14(1):5362. PubMed ID: 37660055
[TBL] [Abstract][Full Text] [Related]
5. Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.
Wu T; Kamikawa YF; Donohoe ME
Cell Rep; 2018 Nov; 25(7):1756-1771. PubMed ID: 30428346
[TBL] [Abstract][Full Text] [Related]
6. Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.
Reynoird N; Schwartz BE; Delvecchio M; Sadoul K; Meyers D; Mukherjee C; Caron C; Kimura H; Rousseaux S; Cole PA; Panne D; French CA; Khochbin S
EMBO J; 2010 Sep; 29(17):2943-52. PubMed ID: 20676058
[TBL] [Abstract][Full Text] [Related]
7. Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.
Morrison-Smith CD; Knox TM; Filic I; Soroko KM; Eschle BK; Wilkens MK; Gokhale PC; Giles F; Griffin A; Brown B; Shapiro GI; Zucconi BE; Cole PA; Lemieux ME; French CA
Mol Cancer Ther; 2020 Jul; 19(7):1406-1414. PubMed ID: 32371576
[TBL] [Abstract][Full Text] [Related]
8. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.
Goel A; Janknecht R
Mol Cell Biol; 2003 Sep; 23(17):6243-54. PubMed ID: 12917345
[TBL] [Abstract][Full Text] [Related]
9. Supercharging BRD4 with NUT in carcinoma.
Eagen KP; French CA
Oncogene; 2021 Feb; 40(8):1396-1408. PubMed ID: 33452461
[TBL] [Abstract][Full Text] [Related]
10. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
11. Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release.
Narita T; Ito S; Higashijima Y; Chu WK; Neumann K; Walter J; Satpathy S; Liebner T; Hamilton WB; Maskey E; Prus G; Shibata M; Iesmantavicius V; Brickman JM; Anastassiadis K; Koseki H; Choudhary C
Mol Cell; 2021 May; 81(10):2166-2182.e6. PubMed ID: 33765415
[TBL] [Abstract][Full Text] [Related]
12. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.
Chen J; Ghazawi FM; Li Q
Epigenetics; 2010 Aug; 5(6):509-15. PubMed ID: 20505343
[TBL] [Abstract][Full Text] [Related]
13. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
15. PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition.
Wang LT; Liu KY; Jeng WY; Chiang CM; Chai CY; Chiou SS; Huang MS; Yokoyama KK; Wang SN; Huang SK; Hsu SH
EMBO Rep; 2020 Feb; 21(2):e48795. PubMed ID: 31908141
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor dimerization activates the p300 acetyltransferase.
Ortega E; Rengachari S; Ibrahim Z; Hoghoughi N; Gaucher J; Holehouse AS; Khochbin S; Panne D
Nature; 2018 Oct; 562(7728):538-544. PubMed ID: 30323286
[TBL] [Abstract][Full Text] [Related]
18. Molecular features driving condensate formation and gene expression by the BRD4-NUT fusion oncoprotein are overlapping but distinct.
Kosno M; Currie SL; Kumar A; Xing C; Rosen MK
Sci Rep; 2023 Jul; 13(1):11907. PubMed ID: 37488172
[TBL] [Abstract][Full Text] [Related]
19. p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone.
Ito T; Ikehara T; Nakagawa T; Kraus WL; Muramatsu M
Genes Dev; 2000 Aug; 14(15):1899-907. PubMed ID: 10921904
[TBL] [Abstract][Full Text] [Related]
20. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.
Faiola F; Liu X; Lo S; Pan S; Zhang K; Lymar E; Farina A; Martinez E
Mol Cell Biol; 2005 Dec; 25(23):10220-34. PubMed ID: 16287840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
